These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 2901907

  • 1. Effects of tiazofurin on protooncogene expression during HL-60 cell differentiation.
    Kharbanda SM, Sherman ML, Spriggs DR, Kufe DW.
    Cancer Res; 1988 Nov 01; 48(21):5965-8. PubMed ID: 2901907
    [Abstract] [Full Text] [Related]

  • 2. Effects of tiazofurin on globin and proto-oncogene expression in K562 erythroleukemia cells.
    Kharbanda SM, Miyazaki K, Takeyama H, Sherman ML, Spriggs DR, Carney WP, Kufe DW.
    Cancer Commun; 1989 Nov 01; 1(3):191-7. PubMed ID: 2639729
    [Abstract] [Full Text] [Related]

  • 3. Effects of the inhibitors of IMP dehydrogenase, tiazofurin and mycophenolic acid, on glycoprotein metabolism.
    Sokoloski JA, Sartorelli AC.
    Mol Pharmacol; 1985 Dec 01; 28(6):567-73. PubMed ID: 2867464
    [Abstract] [Full Text] [Related]

  • 4. Effects of tiazofurin on guanine nucleotide binding regulatory proteins in HL-60 cells.
    Kharbanda SM, Sherman ML, Kufe DW.
    Blood; 1990 Feb 01; 75(3):583-8. PubMed ID: 1967538
    [Abstract] [Full Text] [Related]

  • 5. Alterations in glycoprotein synthesis and guanosine triphosphate levels associated with the differentiation of HL-60 leukemia cells produced by inhibitors of inosine 5'-phosphate dehydrogenase.
    Sokoloski JA, Blair OC, Sartorelli AC.
    Cancer Res; 1986 May 01; 46(5):2314-9. PubMed ID: 2870796
    [Abstract] [Full Text] [Related]

  • 6. Down-regulation of c-myc and c-Ha-ras gene expression by tiazofurin in rat hepatoma cells.
    Olah E, Kote Z, Natsumeda Y, Yamaji Y, Jarai G, Lapis E, Financsek I, Weber G.
    Cancer Biochem Biophys; 1990 Apr 01; 11(2):107-17. PubMed ID: 1974479
    [Abstract] [Full Text] [Related]

  • 7. Biochemically directed therapy of leukemia with tiazofurin, a selective blocker of inosine 5'-phosphate dehydrogenase activity.
    Tricot GJ, Jayaram HN, Lapis E, Natsumeda Y, Nichols CR, Kneebone P, Heerema N, Weber G, Hoffman R.
    Cancer Res; 1989 Jul 01; 49(13):3696-701. PubMed ID: 2567208
    [Abstract] [Full Text] [Related]

  • 8. Induction of erythroid differentiation in K562 cells by inhibitors of inosine monophosphate dehydrogenase.
    Yu J, Lemas V, Page T, Connor JD, Yu AL.
    Cancer Res; 1989 Oct 15; 49(20):5555-60. PubMed ID: 2571408
    [Abstract] [Full Text] [Related]

  • 9. Tiazofurin induction of mouse erythroleukemia cell hemoglobin production in the absence of commitment or changes in protooncogene expression.
    Sherman ML, Shafman TD, Colman MS, Kufe DW.
    Blood; 1989 Feb 15; 73(2):431-4. PubMed ID: 2917182
    [Abstract] [Full Text] [Related]

  • 10. Relationship of acivicin-induced monocytoid differentiation of human myeloid leukemia cells to acivicin-induced modulation of growth factor, cytokine, and protooncogene mRNA expression.
    Weinberg JB, Mason SN.
    Cancer Res; 1991 Feb 15; 51(4):1202-9. PubMed ID: 1997162
    [Abstract] [Full Text] [Related]

  • 11. Biochemical differences among four inosinate dehydrogenase inhibitors, mycophenolic acid, ribavirin, tiazofurin, and selenazofurin, studied in mouse lymphoma cell culture.
    Lee HJ, Pawlak K, Nguyen BT, Robins RK, Sadée W.
    Cancer Res; 1985 Nov 15; 45(11 Pt 1):5512-20. PubMed ID: 2865005
    [Abstract] [Full Text] [Related]

  • 12. Clinical and molecular impact of inhibition of IMP dehydrogenase activity by tiazofurin.
    Weber G, Yamaji Y, Olah E, Natsumeda Y, Jayaram HN, Lapis E, Zhen WN, Prajda N, Hoffman R, Tricot GJ.
    Adv Enzyme Regul; 1989 Nov 15; 28():335-56. PubMed ID: 2576178
    [Abstract] [Full Text] [Related]

  • 13. Induction of cell differentiation in melanoma cells by inhibitors of IMP dehydrogenase: altered patterns of IMP dehydrogenase expression and activity.
    Kiguchi K, Collart FR, Henning-Chubb C, Huberman E.
    Cell Growth Differ; 1990 Jun 15; 1(6):259-70. PubMed ID: 1980599
    [Abstract] [Full Text] [Related]

  • 14. IMP dehydrogenase inhibitor, tiazofurin, induces apoptosis in K562 human erythroleukemia cells.
    Vitale M, Zamai L, Falcieri E, Zauli G, Gobbi P, Santi S, Cinti C, Weber G.
    Cytometry; 1997 Feb 15; 30(1):61-6. PubMed ID: 9056744
    [Abstract] [Full Text] [Related]

  • 15. Regulation of cell proliferation: late down-regulation of c-myb preceding myelo-monocytic cell differentiation.
    Yen A, Samuel V, Forbes M.
    J Cell Physiol; 1992 Oct 15; 153(1):147-56. PubMed ID: 1522128
    [Abstract] [Full Text] [Related]

  • 16. Relationships between the cytotoxicity of tiazofurin and its metabolism by cultured human lung cancer cells.
    Carney DN, Ahluwalia GS, Jayaram HN, Cooney DA, Johns DG.
    J Clin Invest; 1985 Jan 15; 75(1):175-82. PubMed ID: 2856924
    [Abstract] [Full Text] [Related]

  • 17. Multiple mechanisms of regulation of the human c-myb gene during myelomonocytic differentiation.
    Boise LH, Gorse KM, Westin EH.
    Oncogene; 1992 Sep 15; 7(9):1817-25. PubMed ID: 1323820
    [Abstract] [Full Text] [Related]

  • 18. Tiazofurin: molecular and clinical action.
    Weber G, Prajda N, Abonyi M, Look KY, Tricot G.
    Anticancer Res; 1996 Sep 15; 16(6A):3313-22. PubMed ID: 9042306
    [Abstract] [Full Text] [Related]

  • 19. Synergistic action of tiazofurin and retinoic acid on differentiation and colony formation of HL-60 leukemia cells.
    Yamaji Y, Natsumeda Y, Yamada Y, Irino S, Weber G.
    Life Sci; 1990 Sep 15; 46(6):435-42. PubMed ID: 1968220
    [Abstract] [Full Text] [Related]

  • 20. Molecular mechanisms in the antiproliferative action of taxol and tiazofurin.
    Olah E, Csokay B, Prajda N, Kote-Jarai Z, Yeh YA, Weber G.
    Anticancer Res; 1996 Sep 15; 16(5A):2469-77. PubMed ID: 8917337
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.